4//SEC Filing
LaCascia Michael 4
Accession 0001562180-25-000499
CIK 0001822462other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:06 PM ET
Size
9.2 KB
Accession
0001562180-25-000499
Insider Transaction Report
Form 4
LaCascia Michael
Chief Legal Officer
Transactions
- Award
Stock Option (right to buy)
2025-01-22$4.37/sh+126,000$550,620→ 126,000 totalExercise: $4.37Exp: 2035-01-21→ Common Stock (126,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0001831755
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 4:06 PM ET
- Size
- 9.2 KB